Antipsychotic-induced dyslipidemia treated with omega 3 fatty acid supplement in an 11-year-old psychotic child: A 1-year follow-up

摘要

ANT1PSYCHOTIC-INDUCED WEIGHT GAIN AND DYSLIPIDEM1A are hard-to-fight threats that can arise during treatment with second generation antipsychotic drugs (De Hert et al. 2011). The youth population is probably at higher risk than adults for antipsychotic-induced metabolic adverse events, because they are more likely drug naive (Correll et al. 2009; Roy et al. 2010, De Hert et al. 2011). The concern about metabolic complications in youth derives from evidence that metabolic abnormalities and weight gain during childhood strongly predict obesity, metabolic syndrome, hypertension, cardiovascular morbidity, sleep apnea, osteoarthritis, and malignancy risk in adulthood (De Hert et al. 2011; Maayan and Correll 2011).